CLPS
gene geneOn this page
Summary
CLPS (colipase, HGNC:2085) is a protein-coding gene on chromosome 6p21.31, encoding Colipase (P04118). Colipase is a cofactor of pancreatic lipase.
The protein encoded by this gene is a cofactor needed by pancreatic lipase for efficient dietary lipid hydrolysis. It binds to the C-terminal, non-catalytic domain of lipase, thereby stabilizing an active conformation and considerably increasing the overall hydrophobic binding site. The gene product allows lipase to anchor noncovalently to the surface of lipid micelles, counteracting the destabilizing influence of intestinal bile salts. This cofactor is only expressed in pancreatic acinar cells, suggesting regulation of expression by tissue-specific elements. Three transcript variants encoding different isoforms have been found for this gene.
Source: NCBI Gene 1208 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 17 total
- GTEx eGene: eQTL in 9 tissues, sQTL in 1 (q < 0.05)
- Constraint (gnomAD): pLI 0.00 (LoF-tolerant), LOEUF 1.42 (unconstrained)
- MANE Select transcript:
NM_001832
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:2085 |
| Approved symbol | CLPS |
| Name | colipase |
| Location | 6p21.31 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000137392 |
| Ensembl biotype | protein_coding |
| OMIM | 120105 |
| Entrez | 1208 |
Gene structure
Transcript identifiers
Ensembl transcripts: 5 — 5 protein_coding
MANE Select: ENST00000259938
Transcript support level (Ensembl TSL; 1 = fully mRNA-supported): TSL 1: 2, TSL 5: 1
ENST00000259938, ENST00000616014, ENST00000622413, ENST00000912425, ENST00001139944
RefSeq mRNA: 3 — MANE Select: NM_001832
NM_001252597, NM_001252598, NM_001832
CCDS: CCDS4811, CCDS75437, CCDS75438
Canonical transcript exons
ENST00000259938 — 3 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000929523 | 35795731 | 35795853 |
| ENSE00000929524 | 35797205 | 35797323 |
| ENSE00001031985 | 35794982 | 35795277 |
Expression profiles
Bgee: expression breadth ubiquitous, 156 present calls, max score 99.99.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 244.7918 / max 372553.2649, expressed in 28 samples.
Highest expression (Bgee): body of pancreas, pancreas, islet of Langerhans, male germ line stem cell (sensu Vertebrata) in testis, epithelial cell of pancreas.
Genetic regulation across tissues (GTEx eQTL / sQTL)
CLPS is an eGene in GTEx v10 — its expression is genetically regulated (eQTL) in 9 tissues and its splicing (sQTL) in 1 (q < 0.05). Strongest associations first; slope = normalized effect of the lead variant’s alternative allele.
10 significant tissue × QTL associations:
| Tissue | QTL | q-value | Slope | Lead variant |
|---|---|---|---|---|
| Pancreas | eqtl | 5.2e-14 | +0.41 | 6:35780476:A:C |
| Spleen | eqtl | 8.4e-05 | +1.67 | 6:34861810:C:A |
| Brain Amygdala | eqtl | 7.8e-03 | +0.53 | 6:35764754:T:C |
| Esophagus Muscularis | eqtl | 8.0e-03 | -0.86 | 6:36568727:G:A |
| Cells Cultured fibroblasts | eqtl | 1.8e-02 | +0.74 | 6:35508133:G:C |
| Adipose Visceral Omentum | sqtl | 2.0e-02 | +1.11 | 6:36268773:G:C |
| Brain Anterior cingulate cortex BA24 | eqtl | 2.2e-02 | +1.45 | 6:36142157:G:A |
| Adipose Visceral Omentum | eqtl | 3.2e-02 | -0.40 | 6:36376552:T:C |
| Whole Blood | eqtl | 4.1e-02 | +0.23 | 6:36643387:G:GGGGAGCACAGAGCTGGGCCCACA |
| Testis | eqtl | 4.1e-02 | +0.33 | 6:35809731:T:A |
FANTOM5 promoters
1 alternative TSS:
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 73324 | 244.7918 | 28 |
Top tissues by expression
showing 100 of 287 tissues by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| body of pancreas | UBERON:0001150 | 99.99 | gold quality |
| pancreas | UBERON:0001264 | 99.19 | gold quality |
| islet of Langerhans | UBERON:0000006 | 99.10 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 89.81 | gold quality |
| epithelial cell of pancreas | CL:0000083 | 89.20 | gold quality |
| type B pancreatic cell | CL:0000169 | 88.67 | gold quality |
| right coronary artery | UBERON:0001625 | 84.54 | gold quality |
| pancreatic ductal cell | CL:0002079 | 82.31 | silver quality |
| ectocervix | UBERON:0012249 | 82.29 | gold quality |
| right uterine tube | UBERON:0001302 | 80.97 | gold quality |
| descending thoracic aorta | UBERON:0002345 | 80.64 | gold quality |
| right lobe of liver | UBERON:0001114 | 80.55 | gold quality |
| oocyte | CL:0000023 | 80.32 | gold quality |
| endocervix | UBERON:0000458 | 79.92 | gold quality |
| body of stomach | UBERON:0001161 | 79.68 | gold quality |
| metanephros cortex | UBERON:0010533 | 79.10 | gold quality |
| right adrenal gland | UBERON:0001233 | 78.69 | gold quality |
| left uterine tube | UBERON:0001303 | 78.65 | gold quality |
| fundus of stomach | UBERON:0001160 | 76.78 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 74.95 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 74.61 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 74.34 | gold quality |
| secondary oocyte | CL:0000655 | 73.91 | gold quality |
| stomach | UBERON:0000945 | 73.31 | gold quality |
| adrenal cortex | UBERON:0001235 | 73.03 | gold quality |
| left adrenal gland | UBERON:0001234 | 72.68 | gold quality |
| thoracic aorta | UBERON:0001515 | 71.90 | gold quality |
| mucosa of stomach | UBERON:0001199 | 71.86 | gold quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 71.77 | gold quality |
| right ovary | UBERON:0002118 | 71.70 | gold quality |
| spleen | UBERON:0002106 | 70.93 | gold quality |
| transverse colon | UBERON:0001157 | 70.71 | gold quality |
| ascending aorta | UBERON:0001496 | 70.67 | gold quality |
| esophagus mucosa | UBERON:0002469 | 70.44 | gold quality |
| left ovary | UBERON:0002119 | 70.23 | gold quality |
| body of uterus | UBERON:0009853 | 69.61 | gold quality |
| adult organism | UBERON:0007023 | 69.04 | gold quality |
| duodenum | UBERON:0002114 | 68.88 | gold quality |
| parotid gland | UBERON:0001831 | 68.81 | gold quality |
| small intestine Peyer’s patch | UBERON:0003454 | 68.59 | gold quality |
| small intestine | UBERON:0002108 | 68.31 | gold quality |
| lower esophagus | UBERON:0013473 | 68.24 | gold quality |
| apex of heart | UBERON:0002098 | 68.19 | gold quality |
| esophagus | UBERON:0001043 | 68.16 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 68.02 | gold quality |
| jejunal mucosa | UBERON:0000399 | 67.79 | gold quality |
| uterine cervix | UBERON:0000002 | 66.29 | gold quality |
| skeletal muscle tissue of biceps brachii | UBERON:0004502 | 66.25 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 65.75 | gold quality |
| omental fat pad | UBERON:0010414 | 65.28 | gold quality |
| peritoneum | UBERON:0002358 | 65.25 | gold quality |
| esophagogastric junction muscularis propria | UBERON:0035841 | 65.07 | gold quality |
| adipose tissue of abdominal region | UBERON:0007808 | 64.89 | gold quality |
| saliva-secreting gland | UBERON:0001044 | 64.72 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 64.68 | gold quality |
| metanephros | UBERON:0000081 | 64.64 | gold quality |
| adrenal gland | UBERON:0002369 | 64.25 | gold quality |
| aorta | UBERON:0000947 | 63.97 | gold quality |
| muscle layer of sigmoid colon | UBERON:0035805 | 63.87 | gold quality |
| ovary | UBERON:0000992 | 63.83 | gold quality |
| buccal mucosa cell | CL:0002336 | 63.48 | gold quality |
| vagina | UBERON:0000996 | 63.21 | gold quality |
| jejunum | UBERON:0002115 | 62.72 | gold quality |
| cingulate cortex | UBERON:0003027 | 62.68 | gold quality |
| right atrium auricular region | UBERON:0006631 | 62.62 | gold quality |
| colon | UBERON:0001155 | 62.40 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 62.36 | gold quality |
| intestine | UBERON:0000160 | 62.27 | gold quality |
| sigmoid colon | UBERON:0001159 | 62.20 | gold quality |
| minor salivary gland | UBERON:0001830 | 61.99 | gold quality |
| tongue squamous epithelium | UBERON:0006919 | 61.85 | gold quality |
| cardiac atrium | UBERON:0002081 | 61.84 | gold quality |
| prostate gland | UBERON:0002367 | 61.57 | gold quality |
| mouth mucosa | UBERON:0003729 | 61.43 | gold quality |
| vastus lateralis | UBERON:0001379 | 61.33 | gold quality |
| left testis | UBERON:0004533 | 61.33 | gold quality |
| large intestine | UBERON:0000059 | 61.26 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 61.16 | gold quality |
| pituitary gland | UBERON:0000007 | 61.10 | gold quality |
| right frontal lobe | UBERON:0002810 | 60.99 | gold quality |
| coronary artery | UBERON:0001621 | 60.78 | gold quality |
| biceps brachii | UBERON:0001507 | 60.34 | gold quality |
| quadriceps femoris | UBERON:0001377 | 60.19 | gold quality |
| orbitofrontal cortex | UBERON:0004167 | 59.96 | gold quality |
| amygdala | UBERON:0001876 | 59.33 | gold quality |
| Ammon’s horn | UBERON:0001954 | 59.32 | gold quality |
| left coronary artery | UBERON:0001626 | 59.10 | gold quality |
| skin of abdomen | UBERON:0001416 | 58.97 | gold quality |
| Brodmann (1909) area 46 | UBERON:0006483 | 58.87 | gold quality |
| decidua | UBERON:0002450 | 58.67 | gold quality |
| tibial artery | UBERON:0007610 | 58.38 | gold quality |
| myometrium | UBERON:0001296 | 58.29 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 58.22 | gold quality |
| gingiva | UBERON:0001828 | 58.12 | gold quality |
| popliteal artery | UBERON:0002250 | 58.11 | gold quality |
| esophagus squamous epithelium | UBERON:0006920 | 58.11 | silver quality |
| placenta | UBERON:0001987 | 57.92 | gold quality |
| testis | UBERON:0000473 | 57.89 | gold quality |
| right testis | UBERON:0004534 | 57.88 | gold quality |
| anatomical system | UBERON:0000467 | 57.75 | gold quality |
Single-cell (SCXA)
Detected in 5 experiment(s), a significant marker in 3.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-GEOD-81547 | yes | 52515.73 |
| E-ENAD-27 | yes | 6.95 |
| E-HCAD-31 | no | 3.26 |
| E-GEOD-83139 | no | 3.18 |
| E-ANND-3 | no | 0.00 |
HPA expression
RNA tissue specificity: Tissue enriched
41 HPA tissues / cells by nTPM:
| Tissue / cell | Axis | nTPM | Protein (IHC) |
|---|---|---|---|
| Pancreas | tissue | 246873.6 | medium |
| Ovary | tissue | 61.9 | not detected |
| Heart muscle | tissue | 43.3 | not detected |
| Salivary gland | tissue | 39.2 | not detected |
| Duodenum | tissue | 37.9 | not detected |
| Stomach 1 | tissue | 26.1 | not detected |
| Small intestine | tissue | 22.5 | not detected |
| Placenta | tissue | 11.2 | not detected |
| Lymph node | tissue | 9.9 | not detected |
| Bone marrow | tissue | 8.5 | not detected |
| Pituitary gland | tissue | 5.7 | |
| Endometrium 1 | tissue | 5.7 | not detected |
| Appendix | tissue | 5.4 | not detected |
| Epididymis | tissue | 5.3 | not detected |
| Vagina | tissue | 4.7 | not detected |
| Skin 1 | tissue | 3.0 | not detected |
| Hippocampus | tissue | 2.2 | not detected |
| Spleen | tissue | 2.0 | not detected |
| Choroid plexus | tissue | 1.9 | |
| Locus coeruleus | tissue | 1.7 | |
| Prostate | tissue | 1.6 | not detected |
| Postcentral gyrus | tissue | 1.6 | |
| Nucleus accumbens | tissue | 1.2 | |
| Testis | tissue | 1.0 | not detected |
| Lung | tissue | 0.8 | not detected |
| Thyroid gland | tissue | 0.4 | not detected |
| Cerebral cortex | tissue | 0.2 | not detected |
| Urinary bladder | tissue | 0.2 | not detected |
| Motor cortex | tissue | 0.2 | |
| Hippocampal formation | tissue | 0.2 | |
| Insular cortex | tissue | 0.2 | |
| Breast | tissue | 0.1 | not detected |
| Prefrontal cortex | tissue | 0.1 | |
| Adipose tissue | tissue | 0.1 | not detected |
| Esophagus | tissue | 0.1 | not detected |
| Putamen | tissue | 0.1 | |
| Kidney | tissue | 0.1 | not detected |
| Retrosplenial and cingulate cortex | tissue | 0.1 | |
| Fallopian tube | tissue | 0.1 | not detected |
| Somatosensory cortex | tissue | 0.1 | |
| Retrosplenial cortex | tissue | 0.1 |
Brain sub-regions (HPA Brain Atlas): detected in 184; highest nTPM — Blood vessel (25.0), Claustrum (5.1), Hippocampus, CA3 (3.5), Parahippocampal cortex (3.3), Stria terminalis, bed nucleus (3.3).
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
Targeting CLPS by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific).
15 miRNAs:
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-10401-5P | 99.99 | 65.79 | 948 |
| HSA-MIR-378G | 99.71 | 64.90 | 1106 |
| HSA-MIR-6722-3P | 99.45 | 67.62 | 1919 |
| HSA-MIR-2115-3P | 99.31 | 69.68 | 2026 |
| HSA-MIR-1909-3P | 99.03 | 66.56 | 1662 |
| HSA-MIR-4748 | 98.95 | 67.53 | 810 |
| HSA-MIR-3611 | 98.76 | 68.76 | 1290 |
| HSA-MIR-3187-5P | 98.36 | 65.74 | 1776 |
| HSA-MIR-1233-5P | 98.19 | 66.71 | 1201 |
| HSA-MIR-6778-5P | 98.19 | 66.59 | 1239 |
| HSA-MIR-1285-3P | 97.72 | 67.02 | 1932 |
| HSA-MIR-5189-5P | 97.72 | 66.96 | 1814 |
| HSA-MIR-6131 | 97.22 | 66.72 | 960 |
| HSA-MIR-6860 | 97.21 | 66.31 | 1656 |
| HSA-MIR-4486 | 96.96 | 60.61 | 931 |
Functional genomics
gnomAD constraint: pLI 0.00156, LOEUF 1.42, missense Z 0.15 — population loss-of-function intolerance (pLI ≥ 0.9 = LoF-intolerant; lower LOEUF = more constrained). gnomAD
Regional missense constraint (gnomAD RMC): no regional variation along ENST00000259938 — one region, missense o/e 0.99.
Literature-anchored findings (GeneRIF, showing 6)
- evidence in two German Caucasian study populations that the variant of the rare colipase Arg109Cys polymorphism might contribute to increased susceptibility of type 2 diabetes (PMID:16189801)
- Our findings demonstrate that the Arg92Cys polymorphism decreases the function of Cys92 colipase. This change may contribute to the development of type 2 diabetes. (PMID:17715423)
- CLPS genetic variability associates with insulin secretory function in non-diabetic humans and may represent a novel candidate gene for development of type 2 diabetes (PMID:18726866)
- found no evidence for an association of pancreatic colipase(CLPS) single nucleotide polymorphisms rs2766597, rs41270082, rs3748050, and rs3748051 with obesity or percentage of dietary fat intake (PMID:20054203)
- humans with the Arg92Cys substitution will secrete less functional colipase (PMID:23204298)
- Low CLPS expression is associated with pancreatic cancer. (PMID:23918603)
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Clps | ENSMUSG00000024225 |
| rattus_norvegicus | Clps | ENSRNOG00000000510 |
Paralogs (3): CLPSL2 (ENSG00000196748), CLPSL1 (ENSG00000204140), LRCOL1 (ENSG00000204583)
Mouse-model phenotypes
Observed phenotypes of the mouse ortholog (MGI:88421) from MGI (Alliance of Genome Resources) — knockout/mutant phenotypes, ranked by annotation count. 16 distinct phenotype terms.
| Mouse phenotype (MP) | Records |
|---|---|
| postnatal lethality | 2 |
| increased circulating cholesterol level | 2 |
| decreased circulating HDL cholesterol level | 1 |
| sparse hair | 1 |
| decreased body weight | 1 |
| decreased body size | 1 |
| polyphagia | 1 |
| abnormal coat appearance | 1 |
| decreased circulating triglyceride level | 1 |
| steatorrhea | 1 |
| abnormal facial morphology | 1 |
| greasy coat | 1 |
| decreased percent body fat/body weight | 1 |
| slow postnatal weight gain | 1 |
| preweaning lethality, complete penetrance | 1 |
| abnormal facial skin morphology | 1 |
Additional cross-species homologs
Sequence homologs in species beyond Ensembl Compara’s model organisms, by Diamond local protein alignment (% sequence identity; best hit per species). Lower-identity rows are more distant homologs. The matched accessions’ gene symbols aren’t in biobtree yet, so each row shows the UniProt accession.
| Organism | UniProt | Identity | Method |
|---|---|---|---|
| Equus caballus | P02704 | 98.1% | Diamond |
| Bos taurus | A0JNQ7 | 83.6% | Diamond |
| Canis lupus familiaris | P19090 | 83.6% | Diamond |
| Oryctolagus cuniculus | P42890 | 83.0% | Diamond |
| Ictidomys tridecemlineatus | Q91XL7 | 81.1% | Diamond |
| Sus scrofa | P02703 | 80.9% | Diamond |
| Myocastor coypus | P42889 | 77.4% | Diamond |
| Xenopus tropicalis | A9JSD6 | 76.5% | Diamond |
| Gallus gallus | P11148 | 76.5% | Diamond |
| Squalus acanthias | P11149 | 66.7% | Diamond |
Genomic neighbors (locus context)
Genes flanking this one on the chromosome (NCBI/Entrez gene neighborhood). Positional context only — some neighbors share regulatory elements (bidirectional promoters, antisense/overlapping transcripts), but chromosomal adjacency is not itself a functional relationship (see Interactions for that).
| Symbol | Type | Entrez |
|---|---|---|
| SLC26A8 | protein-coding | 116369 |
| LHFPL5 | protein-coding | 222662 |
| SRPK1 | protein-coding | 6732 |
| CLPSL1 | protein-coding | 340204 |
| CLPSL2 | protein-coding | 389383 |
| ARMC12 | protein-coding | 221481 |
Protein
Protein identifiers
Colipase — P04118 (reviewed: P04118)
All UniProt accessions (3): P04118, A0A087WZW1, A0A087X0Q7
UniProt curated annotations — full annotation on UniProt →
Function. Colipase is a cofactor of pancreatic lipase. It allows the lipase to anchor itself to the lipid-water interface. Without colipase the enzyme is washed off by bile salts, which have an inhibitory effect on the lipase. Enterostatin has a biological activity as a satiety signal.
Subunit / interactions. Forms a 1:1 stoichiometric complex with pancreatic lipase.
Subcellular location. Secreted.
Tissue specificity. Expressed by the pancreas.
Polymorphism. Variant Cys-109 is statistically significantly associated with an increased risk of type 2 diabetes.
Similarity. Belongs to the colipase family.
RefSeq proteins (3): NP_001239526, NP_001239527, NP_001823* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001981 | Colipase | Family |
| IPR017913 | Colipase_N | Domain |
| IPR017914 | Colipase_C | Domain |
| IPR017915 | Colipase_CS | Conserved_site |
| IPR047576 | CLPS_chr | Family |
Pfam: PF01114, PF02740
UniProt features (10 total): disulfide bond 5, sequence variant 2, signal peptide 1, propeptide 1, chain 1
Structure
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-P04118-F1 | 87.89 | 0.62 |
Human Protein Atlas
Protein class: Metabolic proteins, Predicted secreted proteins, Predicted intracellular proteins, Plasma proteins
Protein evidence: Evidence at protein level
Antibody reliability (HPA): IH enhanced
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Disulfide bonds (5)
| Type | Positions |
|---|---|
| Disulfide bond | 34–45, 40–56, 44–78, 66–86, 80–104 |
Function
Pathways and Gene Ontology
Reactome pathways
2 curated (TAS) of 9; 0 disease pathways. Curated-first; evidence = TAS (manually curated) vs IEA (electronic inference).
9 pathways:
| ID | Pathway | Evidence |
|---|---|---|
| R-HSA-192456 | Digestion of dietary lipid | curated |
| R-HSA-975634 | Retinoid metabolism and transport | curated |
| R-HSA-8935690 | Digestion | — |
| R-HSA-8963743 | Digestion and absorption | — |
| R-HSA-1430728 | Metabolism | — |
| R-HSA-6806667 | Metabolism of fat-soluble vitamins | — |
| R-HSA-196854 | Metabolism of vitamins and cofactors | — |
| R-HSA-9709957 | Sensory Perception | — |
| R-HSA-2187338 | Visual phototransduction | — |
MSigDB gene sets: 78 (showing top):
GOBP_DIGESTION, GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_UP, CAGCTG_AP4_Q5, GOBP_LIPID_METABOLIC_PROCESS, GOBP_LIPID_CATABOLIC_PROCESS, GOBP_ISOPRENOID_METABOLIC_PROCESS, AP4_01, REACTOME_METABOLISM_OF_VITAMINS_AND_COFACTORS, GOMF_ENZYME_ACTIVATOR_ACTIVITY, KIM_MYCN_AMPLIFICATION_TARGETS_UP, GOBP_RESPONSE_TO_BACTERIUM, GOMF_ENZYME_REGULATOR_ACTIVITY, YOSHIMURA_MAPK8_TARGETS_UP, MARTENS_TRETINOIN_RESPONSE_UP, BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_A
GO Biological Process (5): retinoid metabolic process (GO:0001523), lipid metabolic process (GO:0006629), digestion (GO:0007586), lipid catabolic process (GO:0016042), positive regulation of catalytic activity (GO:0043085)
GO Molecular Function (2): enzyme activator activity (GO:0008047), lipase binding (GO:0035473)
GO Cellular Component (1): extracellular region (GO:0005576)
Reactome top-level categories
7 top-level categories:
| Category | Pathways |
|---|---|
| Digestion | 1 |
| Visual phototransduction | 1 |
| Metabolism of fat-soluble vitamins | 1 |
| Metabolism | 1 |
| Sensory Perception | 1 |
| Metabolism of vitamins and cofactors | 1 |
| Digestion and absorption | 1 |
GO top-level categories
12 GO namespaces:
| Category | Terms |
|---|---|
| catalytic activity | 2 |
| diterpenoid metabolic process | 1 |
| primary metabolic process | 1 |
| multicellular organismal process | 1 |
| lipid metabolic process | 1 |
| catabolic process | 1 |
| positive regulation of molecular function | 1 |
| regulation of catalytic activity | 1 |
| enzyme regulator activity | 1 |
| molecular function activator activity | 1 |
| enzyme binding | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
showing 15 of 456 interactions by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| CLPS | PNLIP | P16233 | 981 |
| CLPS | LIPF | P07098 | 938 |
| CLPS | PNLIPRP1 | P54315 | 927 |
| CLPS | PROK1 | P58294 | 743 |
| CLPS | REG1A | P05451 | 735 |
| CLPS | PROK2 | Q9HC23 | 700 |
| CLPS | DKK4 | Q9UBT3 | 695 |
| CLPS | DKK2 | Q9UBU2 | 689 |
| CLPS | TBX22 | Q9Y458 | 677 |
| CLPS | CEL | P19835 | 664 |
| CLPS | LIPC | P11150 | 577 |
| CLPS | CTRB1 | P17538 | 569 |
| CLPS | LPL | P06858 | 563 |
| CLPS | CLPX | O76031 | 557 |
| CLPS | CTRB2 | Q6GPI1 | 547 |
IntAct
BioGRID (3 interactions; top human partners by supporting records): GLP1R (PCA)
Disease & clinical
Genetic variants
Variant evidence for CLPS: 17 ClinVar records (0 pathogenic / likely pathogenic); 1 GWAS association.
ClinVar
17 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 11 |
| Likely benign | 2 |
| Benign | 2 |
SpliceAI
Top 10 splice-impact sites by Δscore (adjacent positions with the same effect merged into one range; 27 predictions of 132):
| Position(s) | Effect | Δscore | Sites |
|---|---|---|---|
| 6:35797203–35797204 | donor_loss | 0.9900 | 5 |
| 6:35795278–35795279 | acceptor_loss | 0.9800 | 5 |
| 6:35795278 | acceptor_loss | 0.9700 | |
| 6:35797203 | donor_loss | 0.9700 | |
| 6:35795729–35795730 | donor_loss | 0.9500 | 5 |
| 6:35795854–35795855 | acceptor_loss | 0.9500 | 6 |
| 6:35795856 | acceptor_loss | 0.9400 | |
| 6:35795290 | acceptor_gain | 0.9300 | |
| 6:35795859 | acceptor_loss | 0.9300 | |
| 6:35795280 | acceptor_loss | 0.9200 |
AlphaMissense
310 missense substitutions predicted likely pathogenic (of 730 scored), across 83 residues. Top 20 hotspot residues, ranked by the number of likely-pathogenic substitutions (of those reachable by a single-nucleotide change), then by mean score:
| Residue | Likely-pathogenic substitutions | Mean am_pathogenicity | Max am_pathogenicity |
|---|---|---|---|
| D106 | 8 | 0.862 | 0.904 |
| C104 | 7 | 0.991 | 0.997 |
| C34 | 7 | 0.990 | 0.996 |
| C56 | 7 | 0.989 | 0.997 |
| C40 | 7 | 0.987 | 0.997 |
| C45 | 7 | 0.987 | 0.995 |
| C86 | 7 | 0.986 | 0.994 |
| C80 | 7 | 0.985 | 0.993 |
| C66 | 7 | 0.984 | 0.996 |
| C78 | 7 | 0.979 | 0.991 |
| C44 | 7 | 0.976 | 0.989 |
| F101 | 7 | 0.893 | 0.975 |
| E32 | 7 | 0.878 | 0.952 |
| Q39 | 7 | 0.876 | 0.976 |
| N98 | 7 | 0.872 | 0.967 |
| E62 | 7 | 0.846 | 0.936 |
| E81 | 7 | 0.839 | 0.946 |
| G102 | 6 | 0.929 | 0.988 |
| S37 | 6 | 0.910 | 0.965 |
| G94 | 6 | 0.903 | 0.993 |
HPA cancer prognostics
RNA cancer specificity: Cancer enriched (Pancreatic Adenocarcinoma)
Disease associations
OMIM: gene MIM:120105 | disease phenotypes:
GWAS associations
1 associations:
| Study | Trait | p-value |
|---|---|---|
| GCST006585_1362 | Blood protein levels | 6e-80 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (CPIC guideline: no)
CTD chemical–gene interactions
5 total (human), top 5 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| bisphenol A | decreases methylation | 1 |
| sodium arsenite | affects expression | 1 |
| Olive Oil | affects cotreatment, decreases reaction, increases hydrolysis | 1 |
| Orlistat | increases hydrolysis, affects cotreatment, decreases reaction | 1 |
| Valproic Acid | increases methylation | 1 |
Clinical trials (associated diseases)
Via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.